T2 Biosystems Q2 EPS $(0.08) Beats $(0.27) Estimate, Sales $2.00M Miss $2.03M Estimate
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems reported Q2 earnings per share of $(0.08), beating the analyst consensus estimate of $(0.27) by 70.37%. However, the company's quarterly sales of $2.00 million missed the analyst consensus estimate of $2.03 million by 1.48%. This represents a 66.16% decrease in sales compared to the same period last year.
August 07, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
T2 Biosystems beat EPS estimates but missed on sales for Q2. Sales decreased by 66.16% compared to the same period last year.
While T2 Biosystems beat EPS estimates, which is generally a positive signal, the company missed on sales and reported a significant decrease in sales compared to the same period last year. This mixed result could lead to neutral or uncertain short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100